HIGHLIGHTS
- who: Wei Wang from the Department of Hepatobiliary and Surgery, Shanghai Sixth Peopleu2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, SYishan Road, Shanghai, China have published the Article: hENT1u2019s role in adjuvant intra-arterial gemcitabine-based chemotherapy for resectable pancreatic cancer patients, in the Journal: (JOURNAL)
- what: The authors aimed to verify the role of hENT1 as a predictor for patients with resectable ductal adenocarcinoma (PDAC) who underwent radical resection followed by of gemcitabinebased Methods It has been reported that the expression level of hENT1 detected by the specific antibody used in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.